Head-To-Head Survey: Vireo Growth (OTCMKTS:VREOD) versus Alpha Cognition (NASDAQ:ACOG)

Alpha Cognition (NASDAQ:ACOG) and Vireo Growth (OTCMKTS:VREOD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations.

Volatility and Risk

Alpha Cognition has a beta of 2.32, meaning that its stock price is 132% more volatile than the S&P 500. Comparatively, Vireo Growth has a beta of 1.78, meaning that its stock price is 78% more volatile than the S&P 500.

Profitability

This table compares Alpha Cognition and Vireo Growth’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Cognition	-153.61%	-54.60%	-43.47%
Vireo Growth	-23.37%	-19.76%	-7.15%

Analyst Recommendations

This is a breakdown of recent ratings for Alpha Cognition and Vireo Growth, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Cognition	0	0	5	0	3.00
Vireo Growth	1	0	0	0	1.00

Alpha Cognition currently has a consensus target price of $18.00, indicating a potential upside of 102.25%. Given Alpha Cognition’s stronger consensus rating and higher possible upside, analysts clearly believe Alpha Cognition is more favorable than Vireo Growth.

Earnings and Valuation

This table compares Alpha Cognition and Vireo Growth”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Cognition	$10.22 million	18.97	-$20.67 million	($1.10)	-8.09
Vireo Growth	$268.77 million	1.68	-$68.11 million	($3.30)	-3.02

Alpha Cognition has higher earnings, but lower revenue than Vireo Growth. Alpha Cognition is trading at a lower price-to-earnings ratio than Vireo Growth, indicating that it is currently the more affordable of the two stocks.

Summary

Alpha Cognition beats Vireo Growth on 7 of the 12 factors compared between the two stocks.

About Alpha Cognition

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

About Vireo Growth

Goodness Growth Holdings, Inc. operates as a cannabis company in the United States. The company cultivates, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York. The company was formerly known as Vireo Health International Inc. and changed its name to Goodness Growth Holdings, Inc. in June 2021. Goodness Growth Holdings, Inc. is headquartered in Minneapolis, Minnesota.